Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Podcast The Why? Series Tools of the Trade View All Core Series Practice Questions
  • Tweetorials
  • About

Posts by Sindhu Pandurangi

Sindhu Pandurangi

Sindhu Pandurangi

Content Writer

Evidence Corner

SCOPE Index

How does one prognosticate outcomes in pediatric primary sclerosing cholangitis? https://pubmed.ncbi.nlm.nih.gov/32464706/

Sindhu Pandurangi

Sindhu Pandurangi

Kayla Hartjes

Kayla Hartjes

October 23, 2022
Evidence Corner

Medical Therapies in Alagille Syndrome

Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study - ScienceDirect Continuing on with our spotlight on...

Sindhu Pandurangi

Sindhu Pandurangi

April 18, 2022
Clinical Pearls

The Cardiology-Hepatology Axis-Fontan Associated Liver Disease

A 19-year-old male with past medical history of hypoplastic left heart syndrome s/p Fontan surgery 15 years ago is referred to be seen in hepatology clinic for screening for Fontan associated liver...

Sindhu Pandurangi

Sindhu Pandurangi

August 29, 2021
The Why? Series

Why do we use living donors for liver transplantation?

In a very special installment of the Why Series, our adult and pediatric teams join forces to answer the question of how living donor liver transplantation came about in the United States. Read on!

Alyson Kaplan

Alyson Kaplan

Sindhu Pandurangi

Sindhu Pandurangi

March 14, 2021

Subscribe

Enter your email here and receive monthly newsletters with new LFN material.

Registration failed. Please try again later.

Thanks for signing up!

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases